Association of Visual Impairment with Risk for Future Parkinson’s Disease

Abstract

BackgroundAlthough visual dysfunction is one of the most common non-motor symptoms among patients with Parkinson’s disease (PD), it is not known whether such dysfunction predates the onset of clinical PD.ObjectivesTo examine the association of visual impairment (VI) with the future development of PD in the UK Biobank Study.MethodsThe UK Biobank Study is one of the largest prospective cohort studies of health, enrolling over 500,000 participants aged 40-69 years between 2006 and 2010 across the UK. VI was defined as a habitual distance visual acuity (VA) worse than 0.3 LogMAR in the better-seeing eye. Incident cases of PD were determined by self report data, hospital admission records or death records, whichever came first. Multivariable Cox proportional hazard regression models were used to investigate the association between VI and the risk of incident PD.ResultsA total of 117,050 participants were free of PD at the baseline assessment. During the median observation period of 5.96 (interquantile range [IQR]: 5.77-6.23) years, PD occurred in 222 (0.19%) participants. Visually impaired participants were at a higher risk of developing PD than non-VI participants (p<0.001). Compared with the non-VI group, the adjusted hazard ratio was 2.28 (95% CI 1.29-4.04, p=0.005) in the VI group. These results were consistent in the sensitivity analysis, where incident PD cases diagnosed within one year after the baseline assessment were excluded.ConclusionsThis prospective cohort study found that VI was associated with an increased risk of incident PD, suggesting that VI may represent a prodromal feature of PD.

QEEG indices are associated with inflammatory and metabolic risk factors in Parkinson's disease dementia: An observational study

“…Various markers have been associated with PD and these may correlate with disease severity. 1 , 2 To date, there are no reliable objective markers for cognitive severity in PD with dementia (PDD).…”

Efficacy of repetitive transcranial magnetic stimulation in Parkinson's disease: A systematic review and meta-analysis of randomised controlled trials

“…The motor symptoms of PD include bradykinesia, tremor, hypertonia, and gait disorder; and the non-motor symptoms of PD manifest as cognitive impairment and emotional processing, including depression, apathy, visual dysfunction and even cardiovascular autonomic dysfunction. 1 , 2 , 3 , 4 , 5 , 6 …”